Clinical Trials Logo

Clinical Trial Summary

Malnutrition is a prevalent issue among patients undergoing cardiac surgery. This can lead to delirium risk factors, including postoperative functional and cognitive impairment. Assessing the patient's nutritional status before open-heart surgery may decrease the incidence of delirium and the psychological and physiological problems associated with it. The objective of this study was to examine the relationship between nutritional status and the incidence of postoperative delirium in patients who have undergone open-heart surgery.


Clinical Trial Description

Upon examining the literature, it was found that the incidence of delirium after open heart surgery ranged from 3% to 70% (Tomakin et al., 2020). Postoperative delirium has numerous risk factors, including predisposing and accelerating factors. Predisposing risk factors comprise malnutrition and electrolyte imbalance, cognitive impairment, depression, and other psychiatric disorders such as dementia (Velayati et al., 2019; Wilson et al., 2020). This study aims to investigate the relationship between the nutritional status of patients undergoing open heart surgery and the development of postoperative delirium. The study will be conducted in the Cardiovascular Surgery Intensive Care Unit of Bursa Uludag University Health Application and Research Centre Hospital between September 2023 and February 2024. Data will be collected using the Personal Information Form, Nutritional Risk Screening Score 2002 (NRS-2002), Delirium Risk Assessment Form, Visual Analogue Scale for Pain Levels, Richmond Agitation Sedation Scale, Glasgow Coma Scale, and Confusion Assessment Scale in Intensive Care Unit. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06195592
Study type Observational
Source Uludag University
Contact
Status Active, not recruiting
Phase
Start date September 15, 2023
Completion date November 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT00569855 - Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery Phase 2
Active, not recruiting NCT05063370 - Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac Surgery Phase 2